Wednesday, January 4, 2017

BRIEF-Redhill Biopharma to present the positive results of the first phase iii study with rhb-105 for h. Pylori infection

* Redhill Biopharma to present the positive results of the

first phase iii study with RHB-105 for h. Pylori infection at

the innovations in gastroenterology 2017 symposium

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)